Skip to main content
    P

    Pulmatrix Inc (PULM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.29
    -0.01 (-0.76%)

    Market Cap: $4.71M

    Last updated: Nov 17, 2026 at 10:46 AM ET

    Pulmatrix Inc (PULM) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Pulmatrix reported revenue of $0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was -$5.16M, operating cash flow was -$5.43M and free cash flow was -$5.43M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$1.21M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $5.17M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0-100.0%N/AN/AN/A
    Dec 2024$7.81M+7.0%100.0%-125.1%-122.5%
    Dec 2023$7.30M+20.2%100.0%-202.0%-193.5%
    Dec 2022$6.07M+17.5%100.0%-312.1%-310.3%
    Dec 2021$5.17M-59.1%100.0%-390.2%-390.2%
    Dec 2020$12.63M+59.7%100.0%-78.1%-152.8%
    Dec 2019$7.91M+5069.9%100.0%-261.6%-260.4%
    Dec 2018$153.00K-54.3%100.0%-13333.3%-13439.9%
    Dec 2017$335.00K-59.9%100.0%-5216.4%-5389.9%
    Dec 2016$835.00KN/A100.0%-2978.0%-3334.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$7.81M$7.30M$6.07M$5.17M$12.63M$7.91M$153.00K$335.00K$835.00K
    Gross profit$0$7.81M$7.30M$6.07M$5.17M$12.63M$7.91M$153.00K$335.00K$835.00K
    Research and development$38.00K$7.17M$15.52M$18.24M$15.38M$15.61M$12.85M$12.97M$10.24M$10.15M
    Operating income-$5.17M-$9.76M-$14.74M-$18.95M-$20.17M-$9.86M-$20.69M-$20.40M-$17.48M-$24.87M
    Net income-$5.16M-$9.56M-$14.12M-$18.84M-$20.17M-$19.31M-$20.60M-$20.56M-$18.06M-$27.84M
    EBITDAN/A-$9.59M-$13.51M-$17.60M-$18.94MN/A-$20.13M-$20.17M-$17.17MN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$3.00K$366.00K$1.55M$5.88M$2.20M
    Gross profit$0$0$0N/A$0$0$0$3.00K$366.00K$1.55M$5.88M$2.20M
    Operating income-$1.22M-$1.05M-$1.29M-$908.00K-$866.00K-$1.55M-$1.85M-$1.95M-$2.66M-$5.90M$747.00K-$2.23M
    Net income-$1.21M-$1.04M-$1.17M-$928.00K-$877.00K-$1.55M-$1.81M-$1.99M-$2.59M-$5.81M$825.00K-$2.08M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $4.09M were 98.8% of total assets of $4.14M, against total liabilities of $329.00K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$4.14M$9.94M$33.96M$40.95M$58.82M$38.09M$36.10M$14.72M$15.98M$16.66M
    Current assets$4.13M$9.92M$20.84M$38.15M$54.78M$32.46M$31.42M$3.28M$4.25M$4.76M
    Cash and equivalents$4.09M$9.52M$19.17M$35.63M$53.84M$31.66M$23.44M$2.56M$3.55M$4.18M
    Total liabilities$329.00K$996.00K$15.96M$9.84M$11.37M$14.96M$25.08M$2.88M$5.84M$7.90M
    Short-term debtN/AN/A$429.00K$857.00K$1.43M$1.14M$675.00K-$67.00K$3.22M$2.59M
    Long-term debtN/AN/AN/AN/AN/AN/AN/AN/A$0$3.22M
    Shareholder equity$3.81M$8.95M$18.00M$31.11M$47.45M$23.14M$11.02M$11.84M$10.14M$8.76M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.36M$3.25M$4.50M$4.14M$4.98M$6.15M$8.05M$9.94M$11.51M$15.78M$30.39M$33.96M
    Total liabilities$1.02M$689.00K$905.00K$329.00K$249.00K$548.00K$904.00K$996.00K$590.00K$2.47M$11.37M$15.96M
    Cash and equivalents$1.40M$2.17M$3.32M$4.09M$4.79M$5.83M$7.71M$9.52M$10.78M$12.38M$16.30M$19.17M
    Shareholder equity$1.35M$2.56M$3.59M$3.81M$4.73M$5.60M$7.15M$8.95M$10.92M$13.31M$19.02M$18.00M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$5.43M-$10.72M-$15.98M-$19.36M-$19.73M-$12.48M$3.23M-$16.76M-$14.48M-$13.24M
    Capital expenditures$0$398.00K$676.00K$86.00K$144.00K$281.00K$58.00K$19.00K$74.00K$455.00K
    Free cash flow-$5.43M-$11.11M-$16.66M-$19.44M-$19.87M-$12.76M$3.17M-$16.78M-$14.55M-$13.70M
    Dividends paidN/AN/AN/AN/A$3.20MN/AN/AN/A$0$0
    Investing cash flow$0-$398.00K-$676.00K-$86.00K-$144.00K-$281.00K-$58.00K-$19.00K-$74.00K-$431.00K
    Financing cash flow$0$0$53.00K$1.23M$43.48M$20.98M$17.70M$15.79M$13.92M-$1.05M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$770.00K-$1.11M-$1.07M-$706.00K-$1.03M-$1.88M-$1.81M-$1.26M-$3.06M-$3.68M-$2.72M-$2.01M
    Capital expendituresN/AN/A$0$0$0$0$0$0$0$244.00K$154.00K$305.00K
    Free cash flowN/AN/A-$1.07M-$706.00K-$1.03M-$1.88M-$1.81M-$1.26M-$3.06M-$3.92M-$2.87M-$2.32M
    Last 12 quarters

    Frequently Asked Questions About PULM

    What is Pulmatrix's annual revenue?

    Pulmatrix reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    How fast is Pulmatrix's revenue growing?

    Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Pulmatrix profitable?

    No. Pulmatrix reported net income of -$5.16M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does PULM generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$5.43M minus capital expenditures of $0 produced free cash flow of -$5.43M.

    How much debt does Pulmatrix have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $4.09M.